HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer model

Christian Ammitzbøll Juul, Trine Bjørnbo Engel, Frederikke Petrine Fliedner, Lars Ringgaard, Rasmus Eliasen, Fredrik Melander, Martin Bak, Andreas Kjær, Jonas Rosager Henriksen, Dennis Ringkjøbing Elema, Anders Elias Hansen, Thomas Lars Andresen*

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer model'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Engineering

Biochemistry, Genetics and Molecular Biology

Material Science

Pharmacology, Toxicology and Pharmaceutical Science